Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial
2017 · The Lancet · 883 citations
https://doi.org/10.1016/s0140-6736(17)32641-7
Q
Qian Zhou
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
193
Papers
5.7K
Citations
38
h-index
81
i10-index
Qian Zhou is an academic researcher from Chinese Center For Disease Control and Prevention. The author has contributed to research in topics: Inflammatory Bowel Disease & Microscopic Colitis & Gut microbiota and health. The author has an h-index of 38, co-authored 165 publications.
ORCID: 0000-0002-8433-2875Papers by this author
worksEfficacy and Safety of Upadacitinib in a Randomized Trial of Patients With Crohn’s Disease
2020 · Gastroenterology · 303 citations
https://doi.org/10.1053/j.gastro.2020.01.047
Sirtinol promotes PEPCK1 degradation and inhibits gluconeogenesis by inhibiting deacetylase SIRT2
2017 · Scientific Reports · 254 citations
https://doi.org/10.1038/s41598-017-00035-9
Butyrate inhibits interleukin-17 and generates Tregs to ameliorate colorectal colitis in rats
2016 · BMC Gastroenterology · 200 citations
https://doi.org/10.1186/s12876-016-0500-x
Adalimumab maintains remission of Crohn's disease after up to 4 years of treatment: data from <scp>CHARM</scp> and <scp>ADHERE</scp>
2013 · Alimentary Pharmacology & Therapeutics · 110 citations
https://doi.org/10.1111/apt.12499
SIRT2 Promotes the Migration and Invasion of Gastric Cancer through RAS/ERK/JNK/MMP-9 Pathway by Increasing PEPCK1-Related Metabolism
2018 · Neoplasia · 102 citations
https://doi.org/10.1016/j.neo.2018.03.008
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat